POSA223 Dynamics of EU Market Exclusivity: The Impact of Orphan Designation on Generic or Biosimilar Entry

Abstract

Authors

S Collins B Patel R Saada S Kelly

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×